Advertisement

Abstract

The tradition of testing the poisonous properties of food and drink by administering the material to animals extends back through the history of mankind. In some civilizations the expediency of employing human beings as professional ‘tasters’ was an acceptable practice. The use of humans for this sort of testing is unacceptable under present-day moral and ethical values. When we adopt the approach that animal testing may predict pharmacological or toxicological responses for man, we do so from a conviction that there is a common-ground plan for all living matter. Indeed, the major biochemical discoveries of the last three decades lend support for this conviction. As we have come to use animals more to predict the response of humans to drugs, we have come to realize that the similarities between animals and man are great, but so are the differences. In a phrase, we have become pharmacologically sophisticated.

Keywords

Body Surface Area Drug Metabolism Cytosine Arabinoside Drug Plasma Level Selective Toxicity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Adrien Albert, Selective Toxicity, 2nd ed. (Methuen & Co. Ltd., London, John Wiley and Sons, Inc., New York 1960).Google Scholar
  2. [2]
    Earl H. Dearborn, Fed. Proc. 26, 1075 (1967), Symposium on Comparative Pharmacology.Google Scholar
  3. [3]
    R. T. Williams, Clin. Pharmac. Ther. 4, 234 (1963).Google Scholar
  4. [4]
    L. S. Shanker, Pharmac. Rev. 14, 501 (1962).Google Scholar
  5. [5]
    R. R. Levine and E. Pelikan, Ann. Rev. Pharmac. 4, 69 (1964).Google Scholar
  6. [6]
    T. Koppanyi and M. A. Avery, Clin. Pharmac. Ther. 7, 250 (1966).Google Scholar
  7. [7]
    T. C. Butler, Fed. Proc. 17, 1158 (1958).Google Scholar
  8. [8]
    B. B. Brodie, J. Axelrod, J. R. Cooper, L. E. Gaudette, B. N. La Du, C. Mitoma and S. Udenfriend, Science 121, 603 (1955).Google Scholar
  9. [9]
    B. B. Brodie, J. R. Gillette and B. N. La Du, Ann. Rev. Biochem. 27, 427 (1958).Google Scholar
  10. [10]
    J. R. Fouts, Fed. Proc. 21, 1107 (1962).Google Scholar
  11. [11]
    A. H. Conney and J. J. Burns, Adv. Pharmac. 1, 31 (1962).Google Scholar
  12. [12]
    H. Remmer and H. J. Merker, Ann. N. Y. Acad. Sci. 123, 79 (1965).Google Scholar
  13. [13]
    J. R. Fouts and L. G. Hart, Ann. N. Y. Acad. Sci. 123, 245 (1965).Google Scholar
  14. [14]
    R. L. Dixon, L. G. Hart and J. R. Fouts, J. Pharmac. exp. Ther. 133, 7 (1961).Google Scholar
  15. [15]
    B. B. Brodie, J. J. Burns and M. Weiner, Med. exp. 1, 290 (1959).Google Scholar
  16. [16]
    A. H. Conney, Pharmac. Rev. 19, 317 (1967).Google Scholar
  17. [17]
    L. B. Mellett and J. Strobel, Bull., Problems of Drug Dependence, Natl. Acad. Sci.—Natl. Res. Council 5376 (1968).Google Scholar
  18. [18]
    H. G. O. Holck, M. A. Kanan, L. Mills and E. L. Smith, J. Pharmac. 1, 152 (1958).Google Scholar
  19. [19]
    G. P. Quinn, J. Axelrod and B. B. Brodie, Biochem. Pharmac. 1, 152 (1958).Google Scholar
  20. [20]
    D. V. Parke, The Biochemistry of Foreign Compounds (Pergamon Press, London 1968).Google Scholar
  21. [21]
    J. R. Gillette, Progress in Drug Research, 6, 11 (Ed. E. Jucker; Birkhäuser Verlag, Basel 1963).Google Scholar
  22. [22]
    R. T. Williams, Detoxication Mechanism, 2nd ed. (John Wiley and Sons, New York 1959).Google Scholar
  23. [23]
    J. N. Smith, Comparative Biochemistry 6, 403 (Ed. Marcel Florkin and Howard S. Mason; Academic Press, New York 1964).Google Scholar
  24. [24]
    B. B. Brodie and W. D. Reid, Fed. Proc. 29, 1062 (1967).Google Scholar
  25. [25]
    R. T. Williams, Fed. Proc. 29, 1029 (1967).Google Scholar
  26. [26]
    J. R. Cooper and B. B. Brodie, J. Pharmac. exp. Ther. 114, 409 (1955).Google Scholar
  27. [27]
    J. R. Cooper and B. B. Brodie, J. Pharmac. exp. Ther. 120, 75 (1957).Google Scholar
  28. [28]
    F. L. M. Pattison, W. C. Howell and R. W. White, J. Am. chem. Soc. 78, 3487 (1956).Google Scholar
  29. [29]
    P. K. Gessner, D. V. Parke and R. T. Williams, Biochem. J. 79, 482 (1961).Google Scholar
  30. [30]
    H. W. Gerarde and D. W. Ahlstrom, Toxic, appl. Pharmac. 9, 185 (1966).Google Scholar
  31. [31]
    D. V. Parke, Biochem. J. 77, 493 (1960).Google Scholar
  32. [32]
    A. H. Conney, Fed. Proc. 26, 1027 (1967).Google Scholar
  33. [33]
    R. Kuntzman, M. Jacobsen, K. Schneidman and A. H. Conney, J. Pharmac. exp. Ther. 146, 280 (1964).Google Scholar
  34. [34]
    R. Kuntzman, R. Welch and A. H. Conney, Advan. Enzyme Regulation 4, 149 (1966).Google Scholar
  35. [35]
    S. D. Murphy and K. P. Dubois, J. Pharmac. exp. Ther. 124, 194 (1958).Google Scholar
  36. [36]
    J. L. Potter and R. D. O’Brien, Science 144, 55 (1964).Google Scholar
  37. [37]
    R. K. Maller and C. Heidelberger, Cancer Res. 17, 296 (1957).Google Scholar
  38. [38]
    A. N. Craig and H. Jackson, Biochem. Pharmac. 3, 42 (1959).Google Scholar
  39. [39]
    L. B. Mellett and L. A. Woods, Cancer Res. 20, 524 (1960).Google Scholar
  40. [40]
    L. B. Mellett, P. E. Hodgson and L. A. Woods, J. Lab. clin. Med. 60, 818 (1962).Google Scholar
  41. [41]
    J. Reventos, J. Pharm. Pharmac. 6, 217 (1954).Google Scholar
  42. [42]
    V. Williams and F. E. Shideman, J. Pharmac. exp. Ther. 101, 84A (1958).Google Scholar
  43. [43]
    M. T. Bush and E. Saunders, Ann. Rev. Pharmac. 7, 57 (1967).Google Scholar
  44. [44]
    N. P. Salzman and B. B. Brodie, J. Pharmac. exp. Ther. 118, 46 (1956).Google Scholar
  45. [45]
    J. L. Emmerson and T. S. Miya, J. Pharmac. exp. Ther. 137, 148 (1962).Google Scholar
  46. [46]
    R. T. Williams and D. V. Parke, Ann. Rev. Pharmac. 4, 85 (1964).Google Scholar
  47. [47]
    C. H. March and H. W. Elliott, Proc. Soc. exp. Biol. 86, 494 (1954).Google Scholar
  48. [48]
    A. L. Misra, S. J. Mulé and L. A. Woods, Nature 190, 82 (1961).Google Scholar
  49. [49]
    L. B. Mellett and L. A. Woods, Proc. Soc. exp. Biol. 106, 221 (1961).Google Scholar
  50. [50]
    H. W. Elliott, B. M. Tolbert, T. K. Adler and H. H. Anderson, Proc. Soc. exp. Biol. 85, 77 (1954).Google Scholar
  51. [51]
    J. R. Gillette, Fed. Proc. 26, 1040 (1967).Google Scholar
  52. [52]
    J. Cochin, J. Haggart, L. A. Woods and M. H. Seevers, J. Pharmac. exp. Ther. 111, 74 (1954).Google Scholar
  53. [53]
    L. B. Mellett and L. A. Woods, J. Pharmac. exp. Ther. 116, 77 (1956).Google Scholar
  54. [54]
    L. A. Woods, L. B. Mellett and K. S. Andersen, J. Pharmac. exp. Ther. 124, 1 (1958).Google Scholar
  55. [55]
    L. A. Woods, H. E. Muhlenbeck and L. B. Mellett, J. Pharmac. exp. Ther. 117, 117 (1956).Google Scholar
  56. [56]
    E. L. Way and T. K. Adler, Bull. Wld Hlth Org. 26, 51 (1962).Google Scholar
  57. [57]
    J. R. Fouts, J. J. Kamm and B. B. Brodie, J. Pharmac. exp. Ther. 120, 291 (1957).Google Scholar
  58. [58]
    R. H. Adamson, Fed. Proc. 26, 1047 (1967).Google Scholar
  59. [59]
    R. H. Adamson, R. L. Dixon, F. L. Francis and D. P. Rall, Proc. natn. Acad. Sci. 54, 1386 (1965).Google Scholar
  60. [60]
    B. B. Brodie, P. A. Lief and R. Poet, J. Pharmac. Exp. Ther. 94, 359 (1948).Google Scholar
  61. [61]
    B. B. Brodie and W. D. Reid, Fed. Proc. 26, 1062 (1967).Google Scholar
  62. [62]
    R. D. O’Brien, Ann. N. Y. Acad. Sci. 123, 156 (1965).Google Scholar
  63. [63]
    A. Albert, Ann. N. Y. Acad. Sci. 123, 5 (1965).Google Scholar
  64. [64]
    W. Kalow, Ann. Rev. Pharmac. 5, 9 (1965).Google Scholar
  65. [65]
    L. B. Mellett, S. M. Eldareer, D. P. Rall and R. H. Adamson, Archs int. Pharmacodyn. Thér. 177, 60 (1969).Google Scholar
  66. [66]
    J. P. Saunders, Fed. Proc. 26, 1071 (1967).Google Scholar
  67. [67]
    L. B. Mellett (unpublished observations).Google Scholar
  68. [68]
    W. J. Hayes Jr., The Insecticide Dichlorodiphenyltrichloroethane and Its Significance (Ed. P. Müller; Birkhäuser, Basel 1959).Google Scholar
  69. [69]
    R. T. Williams, Biogenesis of Natural Compounds (Ed. P. Bernfeld; Pergamon Press, London 1963).Google Scholar
  70. [70]
    E. Boyland, D. Manson and S. F. D. Orr, Biochem. J. 65, 417 (1957).Google Scholar
  71. [71]
    W. Keller, Annalen 43, 108 (1842).Google Scholar
  72. [72]
    J. N. Smith, Comparative Biochemistry, 6 (Ed. M. Florkin and H. S. Mason; Academic Press, 1965).Google Scholar
  73. [73]
    M. Hitchcock and J. N. Smith, Biochem. J. 93, 392 (1964).Google Scholar
  74. [74]
    E. Boyland, Proc. 1st Int. Pharmac. Meeting, Stockholm, 6, 65 (1962).Google Scholar
  75. [75]
    H. G. Bray, B. G. Humphris, W. V. Thorpe, K. White and P. B. Wood, Biochem, J. 52, 419 (1952).Google Scholar
  76. [76]
    P. K. Knoefel, K. C. Haung and A. Despopoulos, Am. J. Physiol. 196, 1224 (1959).Google Scholar
  77. [77]
    H. G. Bray, B. G. Humphris, W. V. Thorpe, K. White and P. B. Wood, Biochem. J. 59, 162 (1955).Google Scholar
  78. [78]
    Conference on Non-Human Primate Toxicology (Ed. Clem. O. Miller; U.S. Dept. of Health, Education & Welfare, 1966).Google Scholar
  79. [79]
    J. R. Gillette, Fed. Proc. 26, 1040 (1967).Google Scholar
  80. [80]
    J. A. Shannon, Harvey Lectures, Ser. 42, 43 (1945–1946).Google Scholar
  81. [81]
    T. C. Butler, Conference on Non-Human Primate Toxicology (Ed. Clem. O. Miller; U. S. Dept. of Health, Education & Welfare, 1966).Google Scholar
  82. [82]
    D. Pinkel, Cancer Res. 18, 853 (1958).Google Scholar
  83. [83]
    M. Rubner, Z. Biol. 19, 535 (1883).Google Scholar
  84. [84]
    E. Dubois, Basal Metabolism in Health and Disease (Lea and Febiger, Philadelphia 1936).Google Scholar
  85. [85]
    G. Dreyer and W. Ray, Phil. Trans. R. Soc, London [B] 201, 133 (1910).Google Scholar
  86. [86]
    G. Dreyer and W. Ray, Phil. Trans. R. Soc, London [B] 202, 191 (1911).Google Scholar
  87. [87]
    J. Gibson and W. Evans Jr., J. Clin. Invest. 16, 317 (1937).Google Scholar
  88. [88]
    G. Griffin, W. Abbott, M. Pride, E. Muntwyler, F. Mautz and L. Griffith, Ann. Surg. 121, 352 (1945).Google Scholar
  89. [89]
    R. J. Baker, D. Kozoll and K. A. Meyer, Surgery Gynec. Obstet. 104, 183 (1957).Google Scholar
  90. [90]
    A. Grollman, Am. J. Physiol. 90, 210 (1929).Google Scholar
  91. [91]
    H. W. Smith, The Kidney, Structure and Function in Health and Disease (Oxford University Press, New York 1951).Google Scholar
  92. [92]
    E. F. Adolph, Science 109, 579 (1949).Google Scholar
  93. [93]
    D. V. Lindley, J. R. statist. Soc. Supp. 9, 218 (1947).Google Scholar
  94. [94]
    N. Talbot, J. Crawford and A. Butler, New Eng. J. Med. 248, 1100 (1953).Google Scholar
  95. [95]
    E. J. Freireich, E. A. Gehan, D. P. Rall, L. H. Schmidt and H. E. Skipper, Cancer Chemother. Rep. 50, 219 (1966).Google Scholar
  96. [96]
    L.B. Mellett, Fed. Proc. 22, 305 (1963).Google Scholar
  97. [97]
    L. B. Mellett, as quoted by J. P. Saunders, Fed. Proc. 26, 1071 (1967).Google Scholar
  98. [98]
    L. B. Mellett (unpublished data).Google Scholar
  99. [99]
    J. G. Wagner and R. E. Damiano, J. clin. Pharmac. 8, 102 (1968).Google Scholar
  100. [100]
    E. S. Henderson, R. H. Adamson and V. T. Oliverio, Cancer Res. 25, 1018 (1965).Google Scholar
  101. [101]
    E. S. Henderson, R. H. Adamson, C. Denham and V. T. Oliverio, Cancer Res. 25, 1008 (1965).Google Scholar
  102. [102]
    L. B. Mellett (unpublished data).Google Scholar
  103. [103]
    J. D. Crawford, M. E. Terry and G. M. Rourke, Pediatrics 5, 783 (1950).Google Scholar
  104. [104]
    N. B. Eddy and D. Leimbach, J. Pharmac. exp. Ther. 107, 385 (1953).Google Scholar
  105. [105]
    L. B. Mellett and L. A. Woods, Progress in Drug Research 5, 158 (Ed. E. Jucker; Birkhäuser Verlag, Basel 1963).Google Scholar
  106. [106]
    J. Jaffee, Pharmacological Basis of Therapeutics, 3rd ed. (Ed. L. S. Goodman and A. Gilman; McMillan Co., New York 1965).Google Scholar
  107. [107]
    G. T. Okita, Fed. Proc. 26, 1125 (1967).Google Scholar
  108. [108]
    J. J. Burns, Conference on Non-Human Primate Toxicology, 86 (Ed. Clem. O.Miller, Dept. of Health, Education & Welfare, 1966).Google Scholar
  109. [109]
    J. R. Gillette, Ann. N. Y. Acad. Sci. 123, 42 (1965).Google Scholar
  110. [110]
    L. B. Mellett and J. Strobel, Bull., Problems of Drug Dependence, Natl. Acad. Sci.-Natl. Res. Council, Appendix 14, 5388 (1968).Google Scholar
  111. [111]
    J. H. Peters, Am. Rev. resp. Dis. 81, 485 (1960).Google Scholar
  112. [112]
    W. E. Bleidner, J. B. Harmon, W. E. Hewes, T. E. Tynes and E. C. Hermann, J. Pharmac. exp. Ther. 150, 484 (1965).Google Scholar
  113. [113]
    G. W. Camiener and C. G. Smith, Biochem. Pharmac. 14, 1405 (1965).Google Scholar
  114. [114]
    L. T. Mulligan and L. B. Mellett, Pharmacologist 10, 167 (1968).Google Scholar
  115. [115]
    M. B. Chenoweth, Pharmac. Rev. 1, 383 (1949).Google Scholar
  116. [116]
    E. A. Carr, Fed. Proc. 26, 1089 (1967).Google Scholar

Copyright information

© Birkhäuser Verlag Basel 1969

Authors and Affiliations

  1. 1.Kettering-Meyer LaboratoriesSouthern Research InstituteBirminghamUSA

Personalised recommendations